Innovative Reproductive Enhancements | Conceptia | Conceptia



Hero Background Image

Depending on your specific situation and needs, your Conceptia team may recommend various enhancements to your fertility treatments. These innovative reproductive technologies are based on studies and evidence, and allow us to maximize your chance at a healthy pregnancy and delivery.

Explore Enhancements

Endometrial Receptivity Analysis (ERA)


Endometrial Receptivity Analysis, or ERA, can help identify the ideal time in which a female is most receptive to embryo implantation (endometrial receptivity). This cutting-edge technique is performed on patients who have experienced multiple embryo implantation failures. This is a sign of desynchronization between the female’s endometrial receptivity and the embryo’s readiness to be implanted.


ERA consists in the analysis of the female patient’s endometrial cells, to determine their receptiveness at the moment of the collection. This test allows your physician to recommend a personalized embryo transfer protocol and timing to ensure maximal endometrial receptivity and increase your chances of conception.

Fertility Clinic | Monday - Friday: 7:30am - 4:00pm

Nursing Team | Monday - Friday: 7:30am - 3:30pm

Weekends & Holidays: Prescheduled appointments only

Follow us:

Inclusion of all gender and sexually diverse people is an important value of Conceptia. We are continuously striving to create an environment of compassionate belonging where all of the 2SLGBTQ2SIA+ community are supported, valued, and respected.

Conceptia is situated within the traditional unceded territory of the Wolastoqiyik (Maliseet) and Mi’kmaq Peoples. This territory is covered by the “Treaties of Peace and Friendship” which Wolastoqiyik (Maliseet) and Mi’kmaq Peoples first signed with the British Crown in 1725.

We are a proud partner in The Fertility Partners network, Canada’s largest coast-to-coast network of fertility practices. Together, we collaborate on growing access to care, research, and innovation to advance the reproductive medicine field, and delivering leading patient outcomes.